Health
Candidate monoclonal antibody shows hope as COVID-19 treatment – News-Medical.Net
Researchers in the United States have described the effectiveness of a candidate monoclonal antibody currently being evaluated in a Phase 1 trial as a therapy for coronavirus disease 2019 (COVID-19) and its causative agent, severe acute respiratory syndrome c…
Researchers in the United States have described the effectiveness of a candidate monoclonal antibody currently being evaluated in a Phase 1 trial as a therapy for coronavirus disease 2019 (COVID-19) and its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The drug, called CPI-006, targets an immune signaling molecule called CD73 and activates CD73POS B cells, which subsequently promotes antibody production and differentiation into B cells.
In vitro, CPI-006 induce…
-
Noosa News23 hours agoWas Sir Joh ‘God’, as David Littleproud says, or a template for Trump?
-
General21 hours agoAustralian government calls for de-escalation of war in Iran as Coalition endorses US strikes
-
Noosa News22 hours agoNRL live updates: Brisbane Broncos vs Cronulla Sutherland Sharks, Sydney Roosters vs North Queensland Cowboys, Parramatta Eels vs Gold Coast Titans
-
General21 hours agoAustralia urges de-escalation as US strikes Iran